1551P Validation of response and survival biomarkers in a phase II trial of BPM 31510-IV in advanced refractory pancreatic ductal adenocarcinoma (PDAC)
Subbiah, V., Nastke, M.D., Miller, G.M., Shah, P., Gesta, S., Rodrigues, L.O., Granger, E., Narain, N.R., Kiebish, M.A., Sarangarajan, R., Kundranda, M.N.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article